- The 61st Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO)
-
Yoshihara , Sekine M, Nishino K, Enomoto T
- KMID: 2458910
- J Gynecol Oncol.
- 2019 Nov;30(6):e114.
- doi: 10.3802/jgo.2019.30.e114
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Central Nervous System Drug Evaluation Using Positron Emission Tomography
-
Sekine M, Maeda J, Shimada H, Nogami T, Arakawa R, Takano H, Higuchi M, Ito H, Okubo Y, Suhara T
- KMID: 2171280
- Clin Psychopharmacol Neurosci.
- 2011 Apr;9(1):9-16.
In conventional pharmacological research in the field of mental disorders, pharmacological effect and dose have been estimated by ethological approach and in vitro data of affinity to the site of... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
-
Kubuki Y, Shide K, Kameda T, Yamaji T, Sekine M, Kamiunten , Akizuki K, Shimoda H, Tahira Y, Nakamura K, Abe H, Miike T, Iwakiri H, Tahara Y, Sueta M, Hashimoto , Yamamoto S, Hasuike S, Hidaka T, Nagata K, Kitanaka A, Shimoda K
- KMID: 2373635
- Ann Lab Med.
- 2017 Mar;37(2):159-161.
- doi: 10.3343/alm.2017.37.2.159
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Covered self-expandable metallic stents versus plastic stents for endoscopic ultrasound-guided hepaticogastrostomy in patients with malignant biliary obstruction
-
Shibuki T, Okumura K, Sekine M, Kobori I, Miyagaki A, Sasaki Y, Takano Y, Hashimoto Y
- KMID: 2547903
- Clin Endosc.
- 2023 Nov;56(6):802-811.
- doi: 10.5946/ce.2022.211
Background/Aims: Covered self-expandable metallic stents (cSEMS) have become popular for endoscopic ultrasound-guided hepaticogastrostomy with transmural stenting (EUS-HGS). We compared the time to recurrent biliary obstruction (TRBO), complications, and reintervention rates... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy
-
Sekine M, Enomoto T, Arai M, Den H, Nomura H, Ikeuchi T, Nakamura S, the Registration Committee of the Japanese Organization of Hereditary Breast and Ovarian Cancer
- KMID: 2537893
- J Gynecol Oncol.
- 2022 Jul;33(4):e46.
- doi: 10.3802/jgo.2022.33.e46
Objective BRCA1 and BRCA2 mutation carriers are recommended to undergo risk-reducing salpingo-oophorectomy (RRSO) by age 40 and 45, respectively. However, the carriers have a different way of thinking about their life... -
- CITED
-
- Close
- SHARE
-
- Close
